Skip to main content
. 2014 Jul 31;15(8):13437–13460. doi: 10.3390/ijms150813437

Figure 4.

Figure 4

Evolution of joint mobility (range: 0–7) in dogs after aMSCs or PRGF treatment at the 6-months follow up period. The changes which differed significantly with baseline (p < 0.05) are marked as *. Statistically significant differences between groups are marked as †. The green circle is an outlier included in the statistics study.